Protein Z Plasma Levels are Not Elevated in Patients with Non-Arteritic Anterior Ischemic Optic Neuropathy

被引:4
作者
Asproudis, Ioannis [1 ]
Felekis, Taxiarchis L. [1 ]
Gorezis, Spiridon [2 ]
Dova, Lefkothea [3 ]
Dokou, Eleni [3 ]
Vartholomatos, Georgios [2 ]
Aspiotis, Miltiadis [1 ]
Kolaitis, Nikolaos I. [2 ]
机构
[1] Univ Eye Clin Ioannina, Kosti Palama 1, Ioannina 45500, Greece
[2] Epirus Vis Ctr, Ioannina, Greece
[3] Univ Hosp Ioannina, Haematol Lab, Ioannina, Greece
来源
OPEN OPHTHALMOLOGY JOURNAL | 2009年 / 3卷
关键词
Protein Z; Non-arteritic anterior ischemic optic neuropathy;
D O I
10.2174/1874364100903010015
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: Protein Z is a glycoprotein that acts as a co-factor for the inhibition of activated coagulation factor X. Protein Z circulating in abnormal levels has been associated with increased risk for acute ischemic events. Non-arteritic Anterior Ischemic Optic Neuropathy (N-AION) is caused by acute ischemic infarction of the optic nerve head, supplied by the posterior ciliary arteries. Objectives: The aim was to investigate whether there is an association between N-AION and plasma protein Z levels. Patients and Methods: Twenty-six cases of confirmed N-AION and fifty-two controls were included in the study group. Protein Z was estimated in thawed citrate plasma on both N-AION cases and controls by an enzyme immunoassay. The imprecision of the estimation was satisfactory (CV = 4, 6%). Results: The controls' protein Z values distributed within a range 340 to 4200 ng/ml (median = 1420, mean = 1673, SD = 1040 ng/ml). Patients' protein Z values distributed within a range 420 to 3600 ng/ml (median = 1030, mean = 1520, SD = 939 ng/ml). There was no statistical difference between the two distributions (Independent t-test, p= 0.529). Conclusion: In our study, protein Z levels are not implicated in the pathogenesis of non-arteritic anterior ischemic optic neuropathy (N-AION).
引用
收藏
页码:15 / 19
页数:5
相关论文
共 40 条
  • [1] COAGULATION ABNORMALITIES IN ISCHEMIC OPTIC NEUROPATHY
    ACHESON, JF
    SANDERS, MD
    [J]. EYE, 1994, 8 : 89 - 92
  • [2] Protein Z and protein Z-dependent protease inhibitor - Determinants of levels and risk of venous thrombosis
    Al-Shanqeeti, A
    Vlieg, AV
    Berntorp, E
    Rosendaal, FR
    Broze, GJ
    [J]. THROMBOSIS AND HAEMOSTASIS, 2005, 93 (03) : 411 - 413
  • [3] PORTAL OBSTRUCTION IN CHILDREN .1. CLINICAL INVESTIGATION AND HEMORRHAGE RISK
    ALVAREZ, F
    BERNARD, O
    BRUNELLE, F
    HADCHOUEL, P
    ODIEVRE, M
    ALAGILLE, D
    [J]. JOURNAL OF PEDIATRICS, 1983, 103 (05) : 696 - 702
  • [4] BECK RW, 1984, OPHTHALMOLOGY, V91, P1334
  • [5] BERI M, 1987, OPHTHALMOLOGY, V94, P1020
  • [6] PROGRESSIVE AND RECURRENT NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY
    BORCHERT, M
    LESSELL, S
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1988, 106 (04) : 443 - 449
  • [7] Protein Z in patients with pregnancy complications
    Bretelle, F
    Arnoux, D
    Shojai, R
    D'Ercole, C
    Sampol, J
    Dignat, F
    Camoin-Jau, L
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (05) : 1698 - 1702
  • [8] HUMAN PROTEIN-Z
    BROZE, GJ
    MILETICH, JP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (04) : 933 - 938
  • [9] Broze GJ, 2001, THROMB HAEMOSTASIS, V86, P8
  • [10] Low protein Z plasma levels are independently associated with acute coronary syndromes
    Fedi, S
    Sofi, F
    Brogi, D
    Tellini, I
    Cesari, F
    Sestini, I
    Gazzini, A
    Comeglio, M
    Abbate, R
    Gensini, GF
    [J]. THROMBOSIS AND HAEMOSTASIS, 2003, 90 (06) : 1173 - 1178